Self-Limited Epilepsy with Centrotemporal Spikes

Complex MONDO:0007295 Pathograph 15 Show in embeddings browser Epilepsy Neurological Disease

Self-limited epilepsy with centrotemporal spikes (SeLECTS; formerly benign epilepsy with centrotemporal spikes / benign Rolandic epilepsy) is the most common focal epilepsy of childhood. It presents between about ages 3 and 14 years (peak 8-9) in a developmentally normal child, with infrequent focal seizures - characteristically nocturnal, involving one side of the face and the oropharynx (hemifacial twitching, hypersalivation, speech arrest), sometimes evolving to a bilateral tonic-clonic seizure. The EEG hallmark is high-amplitude centrotemporal (Rolandic) spikes that are markedly activated by sleep. Seizures remit by adolescence in almost all cases. It is understood as an age-dependent, genetically influenced disorder of maturation of the perirolandic sensorimotor cortex; during the active period, language and cognitive difficulties can occur and largely improve with remission, though a minority have residual deficits.

Ask OpenScientist

Ask a research question about Self-Limited Epilepsy with Centrotemporal Spikes. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

4
Mappings
1
Inheritance
6
Pathophys.
8
Phenotypes
3
Gaps
15
Pathograph
2
Genes
2
Medical Actions
1
Deep Research
🔗

Mappings

MONDO
MONDO:0007295 self-limited epilepsy with centrotemporal spikes
skos:exactMatch MONDO
MONDO:0007295 is the self-limited epilepsy with centrotemporal spikes concept.
NCIT
NCIT:C116538 Benign Rolandic Epilepsy
skos:exactMatch MONDO:0007295 MONDO:0007295: CONSISTENT
MONDO:0007295 carries NCIT:C116538 as a cross-reference; "benign rolandic epilepsy" is the older clinical designation for the same syndrome.
ICD-10-CM
ICD10CM:G40.0 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
skos:broadMatch manual curation
ICD-10-CM has no dedicated code for this syndrome; it is coded under the G40.0 category, which carries "Benign childhood epilepsy with centrotemporal EEG spikes" as an inclusion term. Recorded as a broadMatch because the category also covers other idiopathic focal epilepsies (e.g. childhood epilepsy with occipital EEG paroxysms).
ICD-11 Foundation
icd11f:1046279423 Benign childhood epilepsy with centro-temporal spikes
skos:exactMatch MONDO:0007295 MONDO:0007295: CONSISTENT
MONDO:0007295 carries icd11.foundation:1046279423 as a cross-reference; the ICD-11 Foundation label uses the older "benign" designation for the syndrome the ILAE now calls self-limited.
NCIT
NCIT:C116538 Benign Rolandic Epilepsy
skos:exactMatch MONDO:0007295 MONDO:0007295: CONSISTENT
MONDO:0007295 carries NCIT:C116538 as a cross-reference; "benign rolandic epilepsy" is the older clinical designation for the same syndrome.
👪

Inheritance

1
Polygenic inheritance HP:0010982
SeLECTS is a genetically complex (polygenic) syndrome rather than a Mendelian disorder. The associated centrotemporal-sharp-wave EEG trait shows heritable, age-dependent, incomplete penetrance (linked to 11p13/ELP4); GRIN2A contributes at the severe end of the epilepsy-aphasia spectrum. Most trait carriers never develop clinical seizures.
Polygenic inheritance
?

Discussions and Knowledge Gaps

3
What determines whether a child with centrotemporal spikes stays at the benign SeLECTS end of the epilepsy-aphasia spectrum or progresses toward the severe end (atypical benign focal epilepsy, epileptic encephalopathy with spike-and-wave activation in sleep, Landau-Kleffner syndrome)?
KNOWLEDGE GAP OPEN gap_selects_epilepsy_aphasia_spectrum_progression
Attached to
pathophysiology#Sleep-Activated Centrotemporal Epileptiform Discharges pathophysiology#Transient Language and Cognitive Dysfunction
SeLECTS is the mild anchor of a continuum whose severe end carries lasting language and cognitive morbidity. GRIN2A variants are enriched at the severe end and are essentially absent from classic SeLECTS, but they explain only a minority even of severe cases, so the factors (genetic, EEG burden in sleep, others) that tip a given child toward encephalopathic outcome are largely unknown. Because the severe end is where irreversible harm occurs, predicting and preventing progression is the central clinical question of the spectrum.
Proposed experiments
Predictors of progression along the epilepsy-aphasia spectrum
prospective predictor cohort experiment Relation: this experiment is of type this experiment type This experiment is of type prospective predictor cohort experiment.
exp_selects_progression_predictors
In a prospective centrotemporal-spike cohort, relate sleep EEG spike burden, genotype, and early language measures to progression toward atypical/encephalopathic outcomes, to identify early predictors.
Readouts
Progression versus baseline predictors
pathophysiology#Transient Language and Cognitive Dysfunction
electroencephalography Relation: this readout is measured by this assay This readout is measured by electroencephalography. neuropsychological assessment Relation: this readout is measured by this assay This readout is measured by neuropsychological assessment.
Direction: POSITIVE
Controls
Non-progressing SeLECTS
Children with typical self-limited course as comparators.
Decision criterion
A predictor is supported if it separates children who progress to the severe end from those with typical remission.
Would support
pathophysiology#Transient Language and Cognitive Dysfunction
Show evidence (1 reference)
PMID:29056244 SUPPORT Human Clinical
"GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
Shows GRIN2A partly explains the severe end but not classic SeLECTS, leaving the determinants of progression largely open.
What maturational change in the perirolandic cortex switches off the age-dependent hyperexcitability and produces the reliable spontaneous remission of SeLECTS by adolescence?
KNOWLEDGE GAP OPEN gap_selects_maturational_remission_mechanism
Attached to
pathophysiology#Age-Dependent Remission pathophysiology#Age-Dependent Perirolandic Cortical Hyperexcitability
Unlike most epilepsies, SeLECTS is programmed to remit as the brain matures, which makes its offset an unusual natural experiment in how a developing cortical network loses a seizure-generating state. The specific maturational processes (changes in inhibition, myelination, synaptic pruning, or network connectivity of the sensorimotor cortex) responsible for remission are not established. Understanding them could illuminate general principles of epileptogenesis and its reversal.
Proposed experiments
Maturational correlates of SeLECTS remission
longitudinal maturation-imaging experiment Relation: this experiment is of type this experiment type This experiment is of type longitudinal maturation-imaging experiment.
exp_selects_remission_maturation
Longitudinally track perirolandic network excitability, inhibitory maturation, and connectivity (EEG, imaging) from active epilepsy through remission, to identify which maturational changes coincide with offset.
Readouts
Excitability and connectivity across remission
pathophysiology#Age-Dependent Remission
electroencephalography Relation: this readout is measured by this assay This readout is measured by electroencephalography. functional magnetic resonance imaging assay Relation: this readout is measured by this assay This readout is measured by functional magnetic resonance imaging assay.
Direction: NEGATIVE
Controls
Age-matched unaffected children
Typically developing children of matched ages.
Decision criterion
A maturational process is implicated if its change reliably coincides with the resolution of centrotemporal spikes and seizures.
Would support
pathophysiology#Age-Dependent Remission
Why do only some carriers of the heritable centrotemporal-sharp-wave (CTS) EEG trait develop clinical seizures, and how does the same 11p13/ELP4 locus connect the EEG trait to the associated speech and language difficulties?
EMERGING HYPOTHESIS OPEN gap_selects_cts_trait_penetrance_and_language_pleiotropy
Attached to
pathophysiology#Genetic Predisposition to Cortical Hyperexcitability pathophysiology#Transient Language and Cognitive Dysfunction
The CTS EEG trait maps to 11p13/ELP4 and is far more common than clinical SeLECTS, so most trait carriers never have seizures - the determinants of this incomplete, age-dependent penetrance are unknown. The same locus shows pleiotropy with developmental verbal dyspraxia, hinting that the EEG trait and the language phenotype share a developmental substrate. Whether ELP4 regulatory variation sets a cortical-excitability and language-network vulnerability that only sometimes crosses the seizure threshold is an open, testable hypothesis.
Proposed experiments
ELP4 regulatory variation, excitability, and language
genotype-endophenotype stratification experiment Relation: this experiment is of type this experiment type This experiment is of type genotype-endophenotype stratification experiment.
exp_selects_elp4_penetrance
In carriers stratified by ELP4 regulatory genotype, relate cortical excitability measures and language-network function to seizure occurrence, testing whether the same variation grades both excitability and language vulnerability.
Readouts
Excitability and language by genotype and seizure status
pathophysiology#Genetic Predisposition to Cortical Hyperexcitability
electroencephalography Relation: this readout is measured by this assay This readout is measured by electroencephalography. language assessment Relation: this readout is measured by this assay This readout is measured by language assessment.
Direction: POSITIVE
Controls
Non-carrier controls
Individuals without the CTS-associated 11p13 genotype.
Decision criterion
The hypothesis is supported if ELP4 regulatory genotype grades both cortical excitability and language-network measures, with seizures occurring above an excitability threshold.
Would support
pathophysiology#Genetic Predisposition to Cortical Hyperexcitability
Show evidence (2 references)
PMID:19172991 SUPPORT Human Clinical
"with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
Establishes the heritable EEG trait locus whose incomplete penetrance and language pleiotropy are the subject of this hypothesis.
PMID:20825490 SUPPORT Human Clinical
"Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves."
Ties the same 11p13 locus to both the EEG trait and developmental verbal dyspraxia, the pleiotropy this hypothesis addresses.
⚙

Pathophysiology

6
Genetic Predisposition to Cortical Hyperexcitability
SeLECTS is genetically complex rather than monogenic: the centrotemporal spike EEG trait is heritable with age-dependent expression, and common and rare variants (including, at the severe/atypical end of the related epilepsy-aphasia spectrum, GRIN2A) contribute susceptibility. This node captures the single concept of the polygenic predisposition.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
ELP4 hgnc:1171 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ELP4 (hgnc:1171). hgnc:1171 is a gene from the HUGO Gene Nomenclature Committee. GRIN2A hgnc:4585 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves GRIN2A (hgnc:4585). hgnc:4585 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Age-Dependent Perirolandic Cortical Hyperexcitability The genetic predisposition manifests as transient hyperexcitability of the maturing perirolandic cortex.
Febrile Seizures In a minority of children the same inherited seizure susceptibility is expressed earlier as febrile seizures, before the centrotemporal-spike epilepsy declares itself; febrile seizures are an antecedent of the syndrome rather than a consequence of its discharges.
Show evidence (2 references)
PMID:19172991 SUPPORT Human Clinical
"with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
Maps the heritable centrotemporal-sharp-wave EEG trait to the 11p13/ELP4 locus, evidence that a genetic cortical-excitability trait underlies the syndrome.
PMID:29056244 SUPPORT Human Clinical
"GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
Shows GRIN2A variants concentrate at the severe end of the epilepsy-aphasia spectrum and are absent from classic BECTS/SeLECTS, distinguishing this complex disorder from the GRIN2A monogenic end.
Age-Dependent Perirolandic Cortical Hyperexcitability
During a maturational window in mid-childhood, the perirolandic (centrotemporal) sensorimotor cortex becomes transiently hyperexcitable; the age-restricted nature of this hyperexcitability underlies both the childhood onset and the spontaneous remission with brain maturation. This node captures the single concept of the maturation-dependent cortical hyperexcitability.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Downstream
Sleep-Activated Centrotemporal Epileptiform Discharges The hyperexcitable perirolandic cortex generates centrotemporal spikes, strongly activated by sleep.
Show evidence (1 reference)
PMID:31645314 SUPPORT Human Clinical
"Children typically present during school-age years, though age of onset has been reported from age 3 months to 14 years"
Supports the maturational-window framing of this node: onset is concentrated in school-age childhood rather than distributed across life, which is what an age-restricted cortical hyperexcitability predicts.
Sleep-Activated Centrotemporal Epileptiform Discharges
The electrographic hallmark is high-amplitude centrotemporal (Rolandic) spike-wave discharges that are markedly potentiated during non-REM sleep. This node captures the single concept of the characteristic epileptiform activity.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Downstream
Focal Sensorimotor (Rolandic) Seizures The discharges manifest clinically as focal perirolandic seizures.
Transient Language and Cognitive Dysfunction Frequent epileptiform activity, especially in sleep, transiently disrupts language and cognitive networks.
Centrotemporal Spikes on EEG The high-amplitude, sleep-activated centrotemporal spike-waves recorded on EEG are the direct scalp expression of these discharges.
Show evidence (2 references)
PMID:22946717 SUPPORT INDIRECT Human Clinical
"The idiopathic focal epilepsies comprise a group of syndromes characterized by focal-onset seizures for which there is no detectable structural brain abnormality and for which there is a proposed functional mechanism for the epilepsy and electroencephalography (EEG) abnormalities."
Supports the functional (rather than lesional) basis of the discharges this node models. Marked INDIRECT because it establishes the absence of a structural lesion and a proposed functional mechanism, from which the functional basis follows, rather than asserting it of this syndrome directly. It does not speak to the non-REM potentiation; the item below carries that half of the node.
PMID:31645314 SUPPORT Human Clinical
"Given the prevalence of neuropsychiatric symptoms coincident with the presentation of epilepsy and abundant spikes during NREM sleep, CECTS is considered a mild epileptic encephalopathy"
Sources the non-REM half of this node, which the entry had previously declared as an open gap: the same prospective cohort describes abundant spikes during NREM sleep as a characteristic of the syndrome.
Focal Sensorimotor (Rolandic) Seizures
The clinical seizures are focal, typically nocturnal, and involve the face and oropharynx (hemifacial twitching, hypersalivation, speech arrest, tonic-clonic activity of one side of the face), sometimes evolving to a bilateral tonic-clonic seizure. This node captures the single concept of the seizure endpoint and conforms to the shared epilepsy final common pathway.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Downstream
Focal-Onset Seizures The perirolandic seizure is a focal-onset seizure, characteristically nocturnal and arising in mid-childhood.
Perioral Paresthesia Onset in the perirolandic somatosensory cortex produces the unilateral perioral or intraoral paresthesia that commonly opens the seizure.
Speech Arrest and Dysarthria Involvement of the oropharyngeal motor strip produces speech arrest and anarthria/dysarthria during the seizure.
Hypersalivation (Drooling) The same oropharyngeal perirolandic involvement produces the near-defining ictal hypersalivation and drooling.
Bilateral Tonic-Clonic Seizures A focal perirolandic seizure may propagate bilaterally and evolve into a bilateral tonic-clonic seizure.
Show evidence (1 reference)
PMID:31645314 SUPPORT Human Clinical
"Approximately half of children will have five or fewer total seizures, approximately 10% will have greater than twenty seizures, and another 10% of children will have over 50 seizures spanning over the course of a decade"
Quantifies the seizure endpoint and its wide variance. Relevant to the entry's treatment framing: the low-count half is the group for whom medication is genuinely optional, and the 10% with over 50 seizures is not.
Transient Language and Cognitive Dysfunction
During the active epilepsy period, deficits in language and executive functioning can occur and largely improve when seizures remit, though a minority have residual deficits. This node captures the single concept of the neuropsychological effect.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Downstream
Language and Learning Difficulties The dysfunction presents clinically as specific language and learning difficulties during the active epilepsy period. Whether it fully resolves with seizure remission is not settled - deficits have been found to persist in children already in remission.
Show evidence (3 references)
PMID:31645314 SUPPORT Human Clinical
"At 9-year follow-up, performance on formal neuropsychological testing was comparable to population statistics and sibling controls."
Directly supports the *transient* qualifier this node carries, which is the harder half of the claim: in a prospective cohort with sibling controls, formal testing at nine years showed no residual deficit.
PMID:31645314 REFUTE Human Clinical
"New or persistent ADHD (20%), mood disorders (23.6%), learning difficulties (14.5%), and behavioral disorders (7.3%) were common after CECTS diagnosis."
Cuts against the *transient* qualifier this node carries. Neuropsychiatric diagnoses are common after diagnosis, and learning difficulty persists in 14.5%, even though group neuropsychological performance normalizes. Kept as a REFUTE rather than dropped, because the node makes a claim about reversibility that this result from the same cohort limits.
PMID:23297860 SUPPORT INDIRECT Human Clinical
"Language reorganization in BECTS patients takes place in bilateral or right hemispheric language networks, with a strong focus in anterior language regions."
Offers a mechanism for how measured performance can stay near normal while the language network is affected: fMRI shows atypical lateralization the authors read as compensatory. Marked INDIRECT because what is measured is the lateralization; that it compensates is the authors' inference, and the node's claim follows only through it.
Age-Dependent Remission
As the perirolandic cortex matures, the hyperexcitability resolves and seizures remit, almost always by adolescence, with normalization of the EEG. This node captures the single concept of the self-limited course, a defining feature of the syndrome.
Neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:31645314 SUPPORT Human Clinical
"Long-term epilepsy outcome is favorable, as almost all children ultimately achieve remission by age 16 years"
States the self-limited course by adolescence that defines this node and names the syndrome.
PMID:31645314 SUPPORT Human Clinical
"Among all children, for each month seizure-free, there was a 6-7% increase in the probability of achieving terminal remission"
Quantifies remission as a progressive process rather than a single event, in a cohort followed a mean of 16 years from diagnosis.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Self-Limited Epilepsy with Centrotemporal Spikes Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

8
Head and Neck 1
Hypersalivation (Drooling) HP:0002307 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Drooling (HP:0002307). HP:0002307 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:1418488 SUPPORT Human Clinical
"The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
Clinical review lists drooling among the defining ictal features of the diurnal focal seizures.
PMID:32661641 SUPPORT Human Clinical
"Case 1: A 9-year-old boy, with normal development, had his first seizure at 8 years old, characterized by paresthesia in his left face, blocking of speech, and drooling."
Video-EEG documentation of a rolandic seizure captures drooling as an ictal manifestation.
Nervous System 7
Focal-Onset Seizures HP:0007359 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal-onset seizure (HP:0007359), qualified as childhood onset. HP:0007359 is a phenotype from the Human Phenotype Ontology.
Onset: CHILDHOOD
Show evidence (2 references)
PMID:31645314 SUPPORT Human Clinical
"self-limited, stereotyped, predominantly nocturnal, hemi-facial motor seizures"
Characterizes the seizure semiology recorded here - nocturnal and hemifacial - and supports the childhood onset category via the same cohort's school-age presentation.
PMID:1418488 SUPPORT Human Clinical
"The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
Clinical review of rolandic epilepsy describes the focal seizures as unilateral facial clonic activity with speech and salivary involvement.
Centrotemporal Spikes on EEG EEG with centrotemporal focal spike waves HP:0012557 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is EEG with centrotemporal focal spike waves (HP:0012557). HP:0012557 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:19172991 SUPPORT Human Clinical
"Focal sharp waves in the centrotemporal area define the electroencephalographic (EEG) trait for the syndrome"
Linkage study of the EEG trait states that centrotemporal focal sharp waves are the defining electrographic feature of the syndrome.
PMID:31645314 SUPPORT Human Clinical
"All subjects had centrotemporal spikes observed on EEG."
Every child in a prospectively enrolled CECTS cohort had the finding, which is what makes it the syndrome's defining electrographic sign rather than a frequent one.
PMID:1418488 SUPPORT Human Clinical
"The EEG abnormalities are unique, consisting of generally high amplitude, centrotemporal spikes that are activated by sleep."
Supports both the high-amplitude morphology and the sleep activation stated in this phenotype's description.
Bilateral Tonic-Clonic Seizures HP:0002069 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral tonic-clonic seizure (HP:0002069). HP:0002069 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31645314 SUPPORT Human Clinical
"hemi-facial motor seizures that can progress to from focal to bilateral tonic-clonic seizures"
Documents the focal-to-bilateral evolution this phenotype records. (The quoted sentence contains a typographical slip in the source, "progress to from focal"; it is transcribed verbatim as required.)
PMID:1418488 SUPPORT Human Clinical
"The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
Clinical review reports nocturnal generalized (bilateral) tonic-clonic seizures as a defining clinical feature of the syndrome.
Speech Arrest and Dysarthria Focal motor seizure with dysarthria/anarthria HP:0032720 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ictal speech arrest and anarthria, annotated with Focal motor seizure with dysarthria/anarthria (HP:0032720). HP:0032720 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:32661641 SUPPORT Human Clinical
"Case 2: A 10-year-old boy, with normal development, started with focal seizures during sleep, characterized by eye and perioral deviation, and speech arrest at age of 7."
Video-EEG documentation of a rolandic seizure captures speech arrest as an ictal manifestation of a focal perirolandic seizure.
PMID:1418488 SUPPORT Human Clinical
"The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
Clinical review lists impaired speech among the ictal features of the focal seizures.
Perioral Paresthesia Focal sensory seizure with somatosensory features HP:0011163 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Perioral ictal paresthesia, annotated with Focal sensory seizure with somatosensory features (HP:0011163). HP:0011163 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32661641 SUPPORT Human Clinical
"Case 1: A 9-year-old boy, with normal development, had his first seizure at 8 years old, characterized by paresthesia in his left face, blocking of speech, and drooling."
Video-EEG documentation captures unilateral facial paresthesia as the leading somatosensory manifestation of a rolandic seizure.
Language and Learning Difficulties Specific learning disability HP:0001328 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Specific learning disability (HP:0001328). HP:0001328 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:31645314 SUPPORT Human Clinical
"Children with CECTS had a high incidence of ADD/ADHD symptoms (18.3%) or learning difficulties (21.7%) before diagnosis."
Quantifies learning difficulty at 21.7%. Note this is measured *before* diagnosis, which complicates the phenotype description's framing of these difficulties as arising during the active epilepsy period.
PMID:39361977 SUPPORT Human Clinical
"34% of children with epilepsy, 18% of children with SeLECTS and 3% of all children in Wales had a neurodevelopmental disorder and or school problems."
Population-level comparison putting neurodevelopmental or school problems in SeLECTS at 18% against a 3% background rate - a six-fold excess, though lower than in childhood epilepsy overall.
PMID:20825490 SUPPORT Human Clinical
"Speech sound disorder (SSD) is a common comorbidity in RE subjects, of unknown etiology, which co-aggregates in family members"
Family study of 38 rolandic epilepsy pedigrees reports speech sound disorder as a common comorbidity of the syndrome.
+ 1 more reference
Febrile Seizures Febrile seizure (within the age range of 3 months to 6 years) HP:0002373 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Febrile seizure, annotated with Febrile seizure (within the age range of 3 months to 6 years) (HP:0002373). HP:0002373 is a phenotype from the Human Phenotype Ontology.
🧬

Genetic Associations

2
ELP4
Gene: ELP4 hgnc:1171 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is ELP4 (hgnc:1171). hgnc:1171 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:19172991 SUPPORT Human Clinical
"with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
Maps the centrotemporal-spike EEG trait to the 11p13/ELP4 locus.
GRIN2A
Gene: GRIN2A hgnc:4585 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is GRIN2A (hgnc:4585). hgnc:4585 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:29056244 SUPPORT Human Clinical
"GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
Shows GRIN2A variants concentrate at the severe end of the spectrum and are absent from classic BECTS/SeLECTS.
💊

Medical Actions

2
Antiseizure Medication (Often Not Required)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Because seizures are infrequent and self-limited, many children need no antiseizure medication; when treatment is used (e.g., for frequent or daytime seizures), standard focal-epilepsy antiseizure medications are effective.
Show evidence (2 references)
PMID:22946717 SUPPORT Human Clinical
"In most patients with the typical focal idiopathic epilepsy syndromes, medication is not necessary."
Supports the "often not required" framing of this treatment.
PMID:31645314 REFUTE Human Clinical
"The majority of children had a seizure while being treated with ASMs, suggesting that CECTS is not as pharmacoresponsive as assumed or that treatment approaches are not optimized."
Contradicts this treatment's claim that standard antiseizure medications "are effective". In a prospective cohort, 29 of 42 treated children still had seizures on treatment. Recorded as REFUTE rather than dropped, because the description makes an efficacy claim and this is the evidence against it; the "often not required" half is supported separately above.
Watchful Observation and Counseling
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Given the benign, self-limited course, reassurance, family counseling, and observation are often sufficient management.
Show evidence (1 reference)
PMID:22946717 SUPPORT Human Clinical
"It may be that a syndrome is benign only when it can be recognized early with reasonable certainty, thereby avoiding unnecessary investigations, overtreatment, and lifestyle restrictions."
Articulates the rationale for observation and counseling over intervention: early confident recognition is what makes avoiding overtreatment and lifestyle restriction possible.
📊

Prevalence

1
Children under 15 years
Annual Incidence 14.0 per 100,000 (7.0–21.0) 1–9 per 10,000 per year
SeLECTS is the most common focal epilepsy of childhood, accounting for roughly 6-7% of all childhood epilepsy and rising to about 15-25% of epilepsies diagnosed between ages 5 and 15. Reported annual incidence in children under 15 is approximately 7-21 per 100,000 (varying with ascertainment method).
Show evidence (2 references)
PMID:31645314 SUPPORT Human Clinical
"CECTS, formally benign epilepsy with centrotemporal spikes, BECTS) is the most common focal childhood epilepsy syndrome, comprising approximately 10% of childhood-onset epilepsy cases"
Supports the "most common focal epilepsy of childhood" claim and puts the share of childhood-onset epilepsy at roughly 10%, in the same range as the 6-7% figure recorded in the notes.
PMID:39361977 REFUTE Human Clinical
"We identified 6,732 children with epilepsy, 186 (3%) with SeLECTS."
A dissenting population estimate, recorded deliberately. This Welsh primary-care cohort found SeLECTS in only 3% of childhood epilepsy and an incidence of 1.1/100,000/year - an order of magnitude below the 7-21 per 100,000 this record encodes. Recorded as REFUTE because it contradicts the rate rather than qualifying it. The authors attribute the difference to under-recording in primary-care coding, but the discrepancy is large enough that the recorded rate should be read as ascertainment-dependent.
{ }

Source YAML

click to show 
name: Self-Limited Epilepsy with Centrotemporal Spikes
creation_date: "2026-07-18T00:00:00Z"
category: Complex
description: >-
  Self-limited epilepsy with centrotemporal spikes (SeLECTS; formerly benign
  epilepsy with centrotemporal spikes / benign Rolandic epilepsy) is the most
  common focal epilepsy of childhood. It presents between about ages 3 and 14
  years (peak 8-9) in a developmentally normal child, with infrequent
  focal seizures - characteristically nocturnal, involving one side of the face
  and the oropharynx (hemifacial twitching, hypersalivation, speech arrest),
  sometimes evolving to a bilateral tonic-clonic seizure. The EEG hallmark is
  high-amplitude centrotemporal (Rolandic) spikes that are markedly activated by
  sleep. Seizures remit by adolescence in almost all cases. It is understood as
  an age-dependent, genetically influenced disorder of maturation of the
  perirolandic sensorimotor cortex; during the active period, language and
  cognitive difficulties can occur and largely improve with remission, though a
  minority have residual deficits.
parents:
- Epilepsy
- Neurological Disease
synonyms:
- SeLECTS
- Benign epilepsy with centrotemporal spikes
- BECTS
- Benign Rolandic epilepsy
- Benign childhood epilepsy with centrotemporal spikes
disease_term:
  preferred_term: self-limited epilepsy with centrotemporal spikes
  term:
    id: MONDO:0007295
    label: self-limited epilepsy with centrotemporal spikes
mappings:
  icd10cm_mappings:
  - term:
      id: ICD10CM:G40.0
      label: Localization-related (focal) (partial) idiopathic epilepsy and epileptic
        syndromes with seizures of localized onset
    mapping_predicate: skos:broadMatch
    mapping_source: manual curation
    mapping_justification: >-
      ICD-10-CM has no dedicated code for this syndrome; it is coded under the
      G40.0 category, which carries "Benign childhood epilepsy with
      centrotemporal EEG spikes" as an inclusion term. Recorded as a broadMatch
      because the category also covers other idiopathic focal epilepsies
      (e.g. childhood epilepsy with occipital EEG paroxysms).
  icd11f_mappings:
  - term:
      id: icd11f:1046279423
      label: Benign childhood epilepsy with centro-temporal spikes
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO:0007295
    mapping_justification: >-
      MONDO:0007295 carries icd11.foundation:1046279423 as a cross-reference;
      the ICD-11 Foundation label uses the older "benign" designation for the
      syndrome the ILAE now calls self-limited.
    consistency:
    - reference: MONDO:0007295
      consistent: CONSISTENT
      notes: "xref: icd11.foundation:1046279423"
  mondo_mappings:
  - term:
      id: MONDO:0007295
      label: self-limited epilepsy with centrotemporal spikes
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0007295 is the self-limited epilepsy with centrotemporal spikes
      concept.
  ncit_mappings:
  - term:
      id: NCIT:C116538
      label: Benign Rolandic Epilepsy
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO:0007295
    mapping_justification: >-
      MONDO:0007295 carries NCIT:C116538 as a cross-reference; "benign rolandic
      epilepsy" is the older clinical designation for the same syndrome.
    consistency:
    - reference: MONDO:0007295
      consistent: CONSISTENT
      notes: "xref: NCIT:C116538"
inheritance:
- name: Polygenic inheritance
  inheritance_term:
    preferred_term: Polygenic inheritance
    term:
      id: HP:0010982
      label: Polygenic inheritance
  description: >-
    SeLECTS is a genetically complex (polygenic) syndrome rather than a Mendelian
    disorder. The associated centrotemporal-sharp-wave EEG trait shows heritable,
    age-dependent, incomplete penetrance (linked to 11p13/ELP4); GRIN2A
    contributes at the severe end of the epilepsy-aphasia spectrum. Most trait
    carriers never develop clinical seizures.
pathophysiology:
- name: Genetic Predisposition to Cortical Hyperexcitability
  description: >-
    SeLECTS is genetically complex rather than monogenic: the centrotemporal
    spike EEG trait is heritable with age-dependent expression, and common and
    rare variants (including, at the severe/atypical end of the related
    epilepsy-aphasia spectrum, GRIN2A) contribute susceptibility. This node
    captures the single concept of the polygenic predisposition.
  role: trigger
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  genes:
  - preferred_term: ELP4
    term:
      id: hgnc:1171
      label: ELP4
    description: >-
      Linkage and fine-mapping of the heritable centrotemporal sharp-wave EEG
      trait to 11p13 variants in ELP4.
  - preferred_term: GRIN2A
    term:
      id: hgnc:4585
      label: GRIN2A
    description: >-
      Contributes at the severe/atypical end of the epilepsy-aphasia spectrum
      rather than to typical SeLECTS: the cited series found GRIN2A mutations in
      Landau-Kleffner syndrome and atypical benign partial epilepsy, but in none
      of its ECSWS or BECTS patients.
  evidence:
  - reference: PMID:19172991
    reference_title: "Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
    explanation: >-
      Maps the heritable centrotemporal-sharp-wave EEG trait to the 11p13/ELP4
      locus, evidence that a genetic cortical-excitability trait underlies the
      syndrome.
  - reference: PMID:29056244
    reference_title: "GRIN2A mutations in epilepsy-aphasia spectrum disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
    explanation: >-
      Shows GRIN2A variants concentrate at the severe end of the epilepsy-aphasia
      spectrum and are absent from classic BECTS/SeLECTS, distinguishing this
      complex disorder from the GRIN2A monogenic end.
  downstream:
  - target: Age-Dependent Perirolandic Cortical Hyperexcitability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The genetic predisposition manifests as transient hyperexcitability of the
      maturing perirolandic cortex.
    evidence:
    - reference: PMID:20825490
      reference_title: "Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Taken together, these data strongly support a neurodevelopmental origin for classic RE."
      explanation: >-
        Linkage of both the centrotemporal-sharp-wave trait and speech sound
        disorder to the same 11p13 locus argues that the inherited
        susceptibility acts through cortical development, which is why the
        resulting hyperexcitability is confined to a maturational window. The
        link is annotated INDIRECT_UNKNOWN_INTERMEDIATES because the steps
        between locus and cortical excitability are not established.
  - target: Febrile Seizures
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      In a minority of children the same inherited seizure susceptibility is
      expressed earlier as febrile seizures, before the centrotemporal-spike
      epilepsy declares itself; febrile seizures are an antecedent of the
      syndrome rather than a consequence of its discharges.
    evidence:
    - reference: PMID:34039076
      reference_title: "Differential Clinical Features in Colombian Patients With Rolandic Epilepsy and Suggestion of Unlikely Association With GRIN2A, RBFOX1, or RBFOX3 Gene Variants."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Personal history of febrile seizures and parasomnias were equally frequent (20%).
      explanation: >-
        Establishes febrile seizures as a personal antecedent in a fifth of a
        rolandic epilepsy cohort. Two cautions apply. The support is indirect: a
        cohort prevalence shows the co-occurrence the edge posits, but does not
        itself demonstrate that a shared inherited susceptibility produces both,
        which is why the edge is typed INDIRECT_UNKNOWN_INTERMEDIATES. And the
        authors describe this Colombian cohort as "clearly different from other
        cohorts", with earlier onset and unusually prevalent febrile seizures
        and parasomnias, so the 20% figure should not be read as a general
        SeLECTS prevalence.
- name: Age-Dependent Perirolandic Cortical Hyperexcitability
  description: >-
    During a maturational window in mid-childhood, the perirolandic
    (centrotemporal) sensorimotor cortex becomes transiently hyperexcitable; the
    age-restricted nature of this hyperexcitability underlies both the
    childhood onset and the spontaneous remission with brain maturation. This
    node captures the single concept of the maturation-dependent cortical
    hyperexcitability.
  role: mediator
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Neuronal Hyperexcitability and Hypersynchrony"
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Children typically present during school-age years, though age of onset has been reported from age 3 months to 14 years"
    explanation: >-
      Supports the maturational-window framing of this node: onset is
      concentrated in school-age childhood rather than distributed across life,
      which is what an age-restricted cortical hyperexcitability predicts.
  downstream:
  - target: Sleep-Activated Centrotemporal Epileptiform Discharges
    causal_link_type: DIRECT
    description: >-
      The hyperexcitable perirolandic cortex generates centrotemporal spikes,
      strongly activated by sleep.
    evidence:
    - reference: PMID:34220477
      reference_title: "Computational Evidence for a Competitive Thalamocortical Model of Spikes and Spindle Activity in Rolandic Epilepsy."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "epileptiform spikes can be triggered and promoted by either a reduced NMDA current or h-type current"
      explanation: >-
        A thalamocortical neural-mass model of rolandic epilepsy shows how
        altered excitability in the Rolandic circuit generates the
        NREM-sleep-activated spikes, the step this edge asserts. Evidence source
        is COMPUTATIONAL because the result comes from in silico simulation.
    - reference: PMID:34220477
      reference_title: "Computational Evidence for a Competitive Thalamocortical Model of Spikes and Spindle Activity in Rolandic Epilepsy."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "changes in inhibitory transmission in the thalamic reticular nucleus mediates an antagonistic dynamic between epileptiform spikes and spindles"
      explanation: >-
        Offers a mechanism for the sleep dependence specifically: the spikes
        compete for the same thalamocortical circuit that generates NREM sleep
        spindles.
- name: Sleep-Activated Centrotemporal Epileptiform Discharges
  description: >-
    The electrographic hallmark is high-amplitude centrotemporal (Rolandic)
    spike-wave discharges that are markedly potentiated during non-REM sleep.
    This node captures the single concept of the characteristic epileptiform
    activity.
  role: central_effector
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:22946717
    reference_title: "Benign childhood focal epilepsies."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "The idiopathic focal epilepsies comprise a group of syndromes characterized by focal-onset seizures for which there is no detectable structural brain abnormality and for which there is a proposed functional mechanism for the epilepsy and electroencephalography (EEG) abnormalities."
    explanation: >-
      Supports the functional (rather than lesional) basis of the discharges
      this node models. Marked INDIRECT because it establishes the absence of a
      structural lesion and a proposed functional mechanism, from which the
      functional basis follows, rather than asserting it of this syndrome
      directly. It does not speak to the non-REM potentiation; the item below
      carries that half of the node.
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Given the prevalence of neuropsychiatric symptoms coincident with the presentation of epilepsy and abundant spikes during NREM sleep, CECTS is considered a mild epileptic encephalopathy"
    explanation: >-
      Sources the non-REM half of this node, which the entry had previously
      declared as an open gap: the same prospective cohort describes abundant
      spikes during NREM sleep as a characteristic of the syndrome.
  downstream:
  - target: Focal Sensorimotor (Rolandic) Seizures
    causal_link_type: DIRECT
    description: >-
      The discharges manifest clinically as focal perirolandic seizures.
    evidence:
    - reference: PMID:32661641
      reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Since seizures associated with rolandic spikes are infrequent and usually occur during sleep"
      explanation: >-
        Ictal video-EEG documents the seizures as the clinical counterpart of
        the rolandic spikes and shares their sleep predominance, which is what
        this edge asserts.
  - target: Transient Language and Cognitive Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Frequent epileptiform activity, especially in sleep, transiently disrupts
      language and cognitive networks.
    evidence:
    - reference: PMID:28801973
      reference_title: "Cognitive functioning in children with self-limited epilepsy with centrotemporal spikes: A systematic review and meta-analysis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "children with ECTS demonstrated significantly lower scores on neuropsychological tests across all cognitive factors compared to healthy controls"
      explanation: >-
        A meta-analysis of 42 case-control samples establishes that the
        cognitive dysfunction is real and measurable, so the target of this edge
        is well supported. Graded PARTIAL rather than SUPPORT because the same
        paper argues the deficits are pervasive rather than circumscribed, which
        cuts against calling them merely transient; the paper does not test
        whether the discharges cause them.
  - target: Centrotemporal Spikes on EEG
    causal_link_type: DIRECT
    description: >-
      The high-amplitude, sleep-activated centrotemporal spike-waves recorded on
      EEG are the direct scalp expression of these discharges.
    evidence:
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The EEG shows characteristic high-voltage sharp waves in the
        centrotemporal regions, which are activated with drowsiness and sleep.
      explanation: >-
        States both the scalp morphology and the sleep activation that this edge
        claims the discharges produce.
- name: Focal Sensorimotor (Rolandic) Seizures
  description: >-
    The clinical seizures are focal, typically nocturnal, and involve the face
    and oropharynx (hemifacial twitching, hypersalivation, speech arrest,
    tonic-clonic activity of one side of the face), sometimes evolving to a
    bilateral tonic-clonic seizure. This node captures the single concept of the
    seizure endpoint and conforms to the shared epilepsy final common pathway.
  role: consequence
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Approximately half of children will have five or fewer total seizures, approximately 10% will have greater than twenty seizures, and another 10% of children will have over 50 seizures spanning over the course of a decade"
    explanation: >-
      Quantifies the seizure endpoint and its wide variance. Relevant to the
      entry's treatment framing: the low-count half is the group for whom
      medication is genuinely optional, and the 10% with over 50 seizures is
      not.
  downstream:
  - target: Focal-Onset Seizures
    causal_link_type: DIRECT
    description: >-
      The perirolandic seizure is a focal-onset seizure, characteristically
      nocturnal and arising in mid-childhood.
    evidence:
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The typical presentation is a partial seizure with parasthesias and
        tonic or clonic activity of the lower face
      explanation: >-
        The syndrome's typical seizure is described as partial (focal) in onset,
        which is what this edge asserts.
  - target: Perioral Paresthesia
    causal_link_type: DIRECT
    description: >-
      Onset in the perirolandic somatosensory cortex produces the unilateral
      perioral or intraoral paresthesia that commonly opens the seizure.
    evidence:
    - reference: PMID:32661641
      reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: characterized by paresthesia in his left face, blocking of speech, and drooling
      explanation: >-
        Ictal video-EEG documentation of unilateral facial paresthesia opening a
        recorded rolandic seizure.
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The typical presentation is a partial seizure with parasthesias and
        tonic or clonic activity of the lower face
      explanation: Places the paresthesia in the lower face, matching the perirolandic onset zone.
  - target: Speech Arrest and Dysarthria
    causal_link_type: DIRECT
    description: >-
      Involvement of the oropharyngeal motor strip produces speech arrest and
      anarthria/dysarthria during the seizure.
    evidence:
    - reference: PMID:32661641
      reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        characterized by eye and perioral deviation, and speech arrest at age
        of 7
      explanation: Ictal video-EEG documentation of speech arrest during a recorded rolandic seizure.
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: associated with drooling and dysarthria
      explanation: Names dysarthria as part of the syndrome's typical seizure.
  - target: Hypersalivation (Drooling)
    causal_link_type: DIRECT
    description: >-
      The same oropharyngeal perirolandic involvement produces the near-defining
      ictal hypersalivation and drooling.
    evidence:
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: associated with drooling and dysarthria
      explanation: Names drooling as part of the syndrome's typical seizure.
    - reference: PMID:32661641
      reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: characterized by paresthesia in his left face, blocking of speech, and drooling
      explanation: Ictal video-EEG documentation of drooling during a recorded rolandic seizure.
  - target: Bilateral Tonic-Clonic Seizures
    causal_link_type: DIRECT
    description: >-
      A focal perirolandic seizure may propagate bilaterally and evolve into a
      bilateral tonic-clonic seizure.
    evidence:
    - reference: PMID:9637591
      reference_title: Benign epilepsy of childhood with centrotemporal spikes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Seizures commonly occur at night and may become secondarily generalized.
      explanation: >-
        Secondary generalization is the pre-2017 term for the focal-to-bilateral
        tonic-clonic evolution this edge asserts.
- name: Transient Language and Cognitive Dysfunction
  description: >-
    During the active epilepsy period, deficits in language and executive
    functioning can occur and largely improve when seizures remit, though a
    minority have residual deficits. This node captures the single concept of
    the neuropsychological effect.
  role: effector
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At 9-year follow-up, performance on formal neuropsychological testing was comparable to population statistics and sibling controls."
    explanation: >-
      Directly supports the *transient* qualifier this node carries, which is
      the harder half of the claim: in a prospective cohort with sibling
      controls, formal testing at nine years showed no residual deficit.
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "New or persistent ADHD (20%), mood disorders (23.6%), learning difficulties (14.5%), and behavioral disorders (7.3%) were common after CECTS diagnosis."
    explanation: >-
      Cuts against the *transient* qualifier this node carries. Neuropsychiatric
      diagnoses are common after diagnosis, and learning difficulty persists in
      14.5%, even though group neuropsychological performance normalizes. Kept
      as a REFUTE rather than dropped, because the node makes a claim about
      reversibility that this result from the same cohort limits.
  - reference: PMID:23297860
    reference_title: "Cognitive impairment and cortical reorganization in children with benign epilepsy with centrotemporal spikes."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Language reorganization in BECTS patients takes place in bilateral or right hemispheric language networks, with a strong focus in anterior language regions."
    explanation: >-
      Offers a mechanism for how measured performance can stay near normal while
      the language network is affected: fMRI shows atypical lateralization the
      authors read as compensatory. Marked INDIRECT because what is measured is
      the lateralization; that it compensates is the authors' inference, and the
      node's claim follows only through it.
  downstream:
  - target: Language and Learning Difficulties
    causal_link_type: DIRECT
    description: >-
      The dysfunction presents clinically as specific language and learning
      difficulties during the active epilepsy period. Whether it fully resolves
      with seizure remission is not settled - deficits have been found to
      persist in children already in remission.
    evidence:
    - reference: PMID:15721962
      reference_title: "Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We found linguistic deficits during the course of epilepsy but also
        persistent deficits in children in remission, suggesting possible
        long-term effects.
      explanation: >-
        Supports the link between the active epilepsy and language impairment,
        and reports deficits persisting in children already in remission, which
        is why this edge does not claim the deficits fully resolve.
    - reference: PMID:21937281
      reference_title: Correlation between language impairment and problems in motor development in children with rolandic epilepsy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Reading performance is impaired in children with rolandic epilepsy.
      explanation: Quantified literacy impairment, the learning-difficulty half of this phenotype.
- name: Age-Dependent Remission
  description: >-
    As the perirolandic cortex matures, the hyperexcitability resolves and
    seizures remit, almost always by adolescence, with normalization of the EEG.
    This node captures the single concept of the self-limited course, a defining
    feature of the syndrome.
  role: consequence
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Long-term epilepsy outcome is favorable, as almost all children ultimately achieve remission by age 16 years"
    explanation: >-
      States the self-limited course by adolescence that defines this node and
      names the syndrome.
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among all children, for each month seizure-free, there was a 6-7% increase in the probability of achieving terminal remission"
    explanation: >-
      Quantifies remission as a progressive process rather than a single event,
      in a cohort followed a mean of 16 years from diagnosis.
phenotypes:
- name: Focal-Onset Seizures
  description: >-
    Focal seizures involving the face and oropharynx, typically nocturnal.
  phenotype_term:
    preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
    onset:
      onset_category: CHILDHOOD
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "self-limited, stereotyped, predominantly nocturnal, hemi-facial motor seizures"
    explanation: >-
      Characterizes the seizure semiology recorded here - nocturnal and
      hemifacial - and supports the childhood onset category via the same
      cohort's school-age presentation.
  - reference: PMID:1418488
    reference_title: "Rolandic epilepsy: clinical and electroencephalographic features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
    explanation: >-
      Clinical review of rolandic epilepsy describes the focal seizures as
      unilateral facial clonic activity with speech and salivary involvement.
- name: Centrotemporal Spikes on EEG
  description: >-
    High-amplitude centrotemporal (Rolandic) focal spike-waves, activated by
    sleep, are the electrographic hallmark.
  phenotype_term:
    preferred_term: EEG with centrotemporal focal spike waves
    term:
      id: HP:0012557
      label: EEG with centrotemporal focal spike waves
  evidence:
  - reference: PMID:19172991
    reference_title: "Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Focal sharp waves in the centrotemporal area define the electroencephalographic (EEG) trait for the syndrome"
    explanation: >-
      Linkage study of the EEG trait states that centrotemporal focal sharp waves
      are the defining electrographic feature of the syndrome.
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All subjects had centrotemporal spikes observed on EEG."
    explanation: >-
      Every child in a prospectively enrolled CECTS cohort had the finding,
      which is what makes it the syndrome's defining electrographic sign rather
      than a frequent one.
  - reference: PMID:1418488
    reference_title: "Rolandic epilepsy: clinical and electroencephalographic features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The EEG abnormalities are unique, consisting of generally high amplitude, centrotemporal spikes that are activated by sleep."
    explanation: >-
      Supports both the high-amplitude morphology and the sleep activation stated
      in this phenotype's description.
- name: Bilateral Tonic-Clonic Seizures
  description: >-
    Focal seizures may evolve to a bilateral (secondarily generalized)
    tonic-clonic seizure.
  phenotype_term:
    preferred_term: Bilateral tonic-clonic seizure
    term:
      id: HP:0002069
      label: Bilateral tonic-clonic seizure
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hemi-facial motor seizures that can progress to from focal to bilateral tonic-clonic seizures"
    explanation: >-
      Documents the focal-to-bilateral evolution this phenotype records. (The
      quoted sentence contains a typographical slip in the source, "progress to
      from focal"; it is transcribed verbatim as required.)
  - reference: PMID:1418488
    reference_title: "Rolandic epilepsy: clinical and electroencephalographic features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
    explanation: >-
      Clinical review reports nocturnal generalized (bilateral) tonic-clonic
      seizures as a defining clinical feature of the syndrome.
- name: Speech Arrest and Dysarthria
  description: >-
    Speech arrest, anarthria, and drooling are characteristic ictal features
    reflecting perirolandic (oropharyngeal) involvement.
  phenotype_term:
    preferred_term: Ictal speech arrest and anarthria
    term:
      id: HP:0032720
      label: Focal motor seizure with dysarthria/anarthria
  evidence:
  - reference: PMID:32661641
    reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Case 2: A 10-year-old boy, with normal development, started with focal seizures during sleep, characterized by eye and perioral deviation, and speech arrest at age of 7."
    explanation: >-
      Video-EEG documentation of a rolandic seizure captures speech arrest as an
      ictal manifestation of a focal perirolandic seizure.
  - reference: PMID:1418488
    reference_title: "Rolandic epilepsy: clinical and electroencephalographic features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
    explanation: >-
      Clinical review lists impaired speech among the ictal features of the focal
      seizures.
- name: Hypersalivation (Drooling)
  description: >-
    Hypersalivation and drooling are near-defining ictal features, reflecting
    the perirolandic (oropharyngeal) seizure onset.
  phenotype_term:
    preferred_term: Drooling
    term:
      id: HP:0002307
      label: Drooling
  evidence:
  - reference: PMID:1418488
    reference_title: "Rolandic epilepsy: clinical and electroencephalographic features."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disorder is marked clinically by nocturnal generalized tonic-clonic seizures and diurnal seizures consisting of simple partial seizures consisting of brief unilateral facial clonic activity, dysphasia, and drooling."
    explanation: >-
      Clinical review lists drooling among the defining ictal features of the
      diurnal focal seizures.
  - reference: PMID:32661641
    reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Case 1: A 9-year-old boy, with normal development, had his first seizure at 8 years old, characterized by paresthesia in his left face, blocking of speech, and drooling."
    explanation: >-
      Video-EEG documentation of a rolandic seizure captures drooling as an ictal
      manifestation.
- name: Perioral Paresthesia
  description: >-
    Unilateral perioral or intraoral somatosensory symptoms (paresthesia) are a
    common ictal aura.
  phenotype_term:
    preferred_term: Perioral ictal paresthesia
    term:
      id: HP:0011163
      label: Focal sensory seizure with somatosensory features
  evidence:
  - reference: PMID:32661641
    reference_title: "Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Case 1: A 9-year-old boy, with normal development, had his first seizure at 8 years old, characterized by paresthesia in his left face, blocking of speech, and drooling."
    explanation: >-
      Video-EEG documentation captures unilateral facial paresthesia as the
      leading somatosensory manifestation of a rolandic seizure.
- name: Language and Learning Difficulties
  description: >-
    Specific learning and language difficulties can occur during the active
    epilepsy period and largely improve with remission, though a minority
    persist.
  phenotype_term:
    preferred_term: Specific learning disability
    term:
      id: HP:0001328
      label: Specific learning disability
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Children with CECTS had a high incidence of ADD/ADHD symptoms (18.3%) or learning difficulties (21.7%) before diagnosis."
    explanation: >-
      Quantifies learning difficulty at 21.7%. Note this is measured *before*
      diagnosis, which complicates the phenotype description's framing of these
      difficulties as arising during the active epilepsy period.
  - reference: PMID:39361977
    reference_title: "Epidemiology of self-limited epilepsy with centrotemporal spikes (SeLECTS): A population study using primary care records."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "34% of children with epilepsy, 18% of children with SeLECTS and 3% of all children in Wales had a neurodevelopmental disorder and or school problems."
    explanation: >-
      Population-level comparison putting neurodevelopmental or school problems
      in SeLECTS at 18% against a 3% background rate - a six-fold excess, though
      lower than in childhood epilepsy overall.
  - reference: PMID:20825490
    reference_title: "Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Speech sound disorder (SSD) is a common comorbidity in RE subjects, of unknown etiology, which co-aggregates in family members"
    explanation: >-
      Family study of 38 rolandic epilepsy pedigrees reports speech sound
      disorder as a common comorbidity of the syndrome.
  - reference: PMID:32179505
    reference_title: "Electroencephalographic abnormalities are correlated with cognitive deficits in children with benign childhood epilepsy with centrotemporal spikes: A clinical study of 61 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with a high NREM sleep discharge index (≥55%) in the first sleep cycle exhibited significantly lower scores for arithmetic calculation, executive function, and attention and memory tests than patients with a low discharge index (<55%)."
    explanation: >-
      Controlled neuropsychological study of 61 children with the syndrome shows
      measurable learning deficits that track the burden of sleep-activated
      discharges, consistent with difficulties during the active epilepsy period.
- name: Febrile Seizures
  description: A history of febrile seizures precedes the epilepsy in a minority.
  phenotype_term:
    preferred_term: Febrile seizure
    term:
      id: HP:0002373
      label: Febrile seizure (within the age range of 3 months to 6 years)
genetic:
- name: ELP4
  gene_term:
    preferred_term: ELP4
    term:
      id: hgnc:1171
      label: ELP4
  relationship_type: SUSCEPTIBILITY
  notes: >-
    The heritable centrotemporal-sharp-wave EEG trait maps to the 11p13 locus
    containing ELP4 (Elongator complex subunit 4); associated variants are
    largely non-coding/regulatory. This is a susceptibility trait, not a single
    Mendelian cause; SeLECTS is genetically complex.
  evidence:
  - reference: PMID:19172991
    reference_title: "Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
    explanation: >-
      Maps the centrotemporal-spike EEG trait to the 11p13/ELP4 locus.
- name: GRIN2A
  gene_term:
    preferred_term: GRIN2A
    term:
      id: hgnc:4585
      label: GRIN2A
  relationship_type: SUSCEPTIBILITY
  notes: >-
    GRIN2A (encoding the NMDA receptor subunit GluN2A) variants cluster at the
    severe/atypical end of the epilepsy-aphasia spectrum (Landau-Kleffner
    syndrome, atypical benign focal epilepsy, EE-SWAS) and are essentially absent
    from classic SeLECTS/BECTS - a distinction from the GRIN2A monogenic
    disorders.
  evidence:
  - reference: PMID:29056244
    reference_title: "GRIN2A mutations in epilepsy-aphasia spectrum disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
    explanation: >-
      Shows GRIN2A variants concentrate at the severe end of the spectrum and are
      absent from classic BECTS/SeLECTS.
treatments:
- name: Antiseizure Medication (Often Not Required)
  description: >-
    Because seizures are infrequent and self-limited, many children need no
    antiseizure medication; when treatment is used (e.g., for frequent or
    daytime seizures), standard focal-epilepsy antiseizure medications are
    effective.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:22946717
    reference_title: "Benign childhood focal epilepsies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In most patients with the typical focal idiopathic epilepsy syndromes, medication is not necessary."
    explanation: >-
      Supports the "often not required" framing of this treatment.
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "The majority of children had a seizure while being treated with ASMs, suggesting that CECTS is not as pharmacoresponsive as assumed or that treatment approaches are not optimized."
    explanation: >-
      Contradicts this treatment's claim that standard antiseizure medications
      "are effective". In a prospective cohort, 29 of 42 treated children still
      had seizures on treatment. Recorded as REFUTE rather than dropped, because
      the description makes an efficacy claim and this is the evidence against
      it; the "often not required" half is supported separately above.
- name: Watchful Observation and Counseling
  description: >-
    Given the benign, self-limited course, reassurance, family counseling, and
    observation are often sufficient management.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:22946717
    reference_title: "Benign childhood focal epilepsies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It may be that a syndrome is benign only when it can be recognized early with reasonable certainty, thereby avoiding unnecessary investigations, overtreatment, and lifestyle restrictions."
    explanation: >-
      Articulates the rationale for observation and counseling over
      intervention: early confident recognition is what makes avoiding
      overtreatment and lifestyle restriction possible.
prevalence:
- population: Children under 15 years
  measure_type: ANNUAL_INCIDENCE
  prevalence_class: BAND_1_5_PER_10000
  rate_per_100000: 14.0
  rate_low: 7.0
  rate_high: 21.0
  notes: >-
    SeLECTS is the most common focal epilepsy of childhood, accounting for
    roughly 6-7% of all childhood epilepsy and rising to about 15-25% of
    epilepsies diagnosed between ages 5 and 15. Reported annual incidence in
    children under 15 is approximately 7-21 per 100,000 (varying with
    ascertainment method).
  evidence:
  - reference: PMID:31645314
    reference_title: "The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CECTS, formally benign epilepsy with centrotemporal spikes, BECTS) is the most common focal childhood epilepsy syndrome, comprising approximately 10% of childhood-onset epilepsy cases"
    explanation: >-
      Supports the "most common focal epilepsy of childhood" claim and puts the
      share of childhood-onset epilepsy at roughly 10%, in the same range as the
      6-7% figure recorded in the notes.
  - reference: PMID:39361977
    reference_title: "Epidemiology of self-limited epilepsy with centrotemporal spikes (SeLECTS): A population study using primary care records."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified 6,732 children with epilepsy, 186 (3%) with SeLECTS."
    explanation: >-
      A dissenting population estimate, recorded deliberately. This Welsh
      primary-care cohort found SeLECTS in only 3% of childhood epilepsy and an
      incidence of 1.1/100,000/year - an order of magnitude below the 7-21 per
      100,000 this record encodes. Recorded as REFUTE because it contradicts the
      rate rather than qualifying it. The authors attribute the difference to
      under-recording in primary-care coding, but the discrepancy is large
      enough that the recorded rate should be read as ascertainment-dependent.
datasets: []
discussions:
- discussion_id: gap_selects_epilepsy_aphasia_spectrum_progression
  prompt: >-
    What determines whether a child with centrotemporal spikes stays at the
    benign SeLECTS end of the epilepsy-aphasia spectrum or progresses toward the
    severe end (atypical benign focal epilepsy, epileptic encephalopathy with
    spike-and-wave activation in sleep, Landau-Kleffner syndrome)?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Sleep-Activated Centrotemporal Epileptiform Discharges
  - pathophysiology#Transient Language and Cognitive Dysfunction
  rationale: >-
    SeLECTS is the mild anchor of a continuum whose severe end carries lasting
    language and cognitive morbidity. GRIN2A variants are enriched at the severe
    end and are essentially absent from classic SeLECTS, but they explain only a
    minority even of severe cases, so the factors (genetic, EEG burden in sleep,
    others) that tip a given child toward encephalopathic outcome are largely
    unknown. Because the severe end is where irreversible harm occurs, predicting
    and preventing progression is the central clinical question of the spectrum.
  evidence:
  - reference: PMID:29056244
    reference_title: "GRIN2A mutations in epilepsy-aphasia spectrum disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS."
    explanation: >-
      Shows GRIN2A partly explains the severe end but not classic SeLECTS,
      leaving the determinants of progression largely open.
  proposed_experiments:
  - experiment_id: exp_selects_progression_predictors
    name: Predictors of progression along the epilepsy-aphasia spectrum
    description: >-
      In a prospective centrotemporal-spike cohort, relate sleep EEG spike
      burden, genotype, and early language measures to progression toward
      atypical/encephalopathic outcomes, to identify early predictors.
    experiment_type:
      preferred_term: prospective predictor cohort experiment
    readouts:
    - name: Progression versus baseline predictors
      target: pathophysiology#Transient Language and Cognitive Dysfunction
      assays:
      - preferred_term: electroencephalography
      - preferred_term: neuropsychological assessment
      direction: POSITIVE
    controls:
    - name: Non-progressing SeLECTS
      description: Children with typical self-limited course as comparators.
    decision_criterion: >-
      A predictor is supported if it separates children who progress to the
      severe end from those with typical remission.
    would_support:
    - pathophysiology#Transient Language and Cognitive Dysfunction

- discussion_id: gap_selects_maturational_remission_mechanism
  prompt: >-
    What maturational change in the perirolandic cortex switches off the
    age-dependent hyperexcitability and produces the reliable spontaneous
    remission of SeLECTS by adolescence?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Age-Dependent Remission
  - pathophysiology#Age-Dependent Perirolandic Cortical Hyperexcitability
  rationale: >-
    Unlike most epilepsies, SeLECTS is programmed to remit as the brain matures,
    which makes its offset an unusual natural experiment in how a developing
    cortical network loses a seizure-generating state. The specific maturational
    processes (changes in inhibition, myelination, synaptic pruning, or network
    connectivity of the sensorimotor cortex) responsible for remission are not
    established. Understanding them could illuminate general principles of
    epileptogenesis and its reversal.
  proposed_experiments:
  - experiment_id: exp_selects_remission_maturation
    name: Maturational correlates of SeLECTS remission
    description: >-
      Longitudinally track perirolandic network excitability, inhibitory
      maturation, and connectivity (EEG, imaging) from active epilepsy through
      remission, to identify which maturational changes coincide with offset.
    experiment_type:
      preferred_term: longitudinal maturation-imaging experiment
    readouts:
    - name: Excitability and connectivity across remission
      target: pathophysiology#Age-Dependent Remission
      assays:
      - preferred_term: electroencephalography
      - preferred_term: functional magnetic resonance imaging assay
      direction: NEGATIVE
    controls:
    - name: Age-matched unaffected children
      description: Typically developing children of matched ages.
    decision_criterion: >-
      A maturational process is implicated if its change reliably coincides with
      the resolution of centrotemporal spikes and seizures.
    would_support:
    - pathophysiology#Age-Dependent Remission

- discussion_id: gap_selects_cts_trait_penetrance_and_language_pleiotropy
  prompt: >-
    Why do only some carriers of the heritable centrotemporal-sharp-wave (CTS)
    EEG trait develop clinical seizures, and how does the same 11p13/ELP4 locus
    connect the EEG trait to the associated speech and language difficulties?
  kind: EMERGING_HYPOTHESIS
  status: OPEN
  attaches_to:
  - pathophysiology#Genetic Predisposition to Cortical Hyperexcitability
  - pathophysiology#Transient Language and Cognitive Dysfunction
  rationale: >-
    The CTS EEG trait maps to 11p13/ELP4 and is far more common than clinical
    SeLECTS, so most trait carriers never have seizures - the determinants of
    this incomplete, age-dependent penetrance are unknown. The same locus shows
    pleiotropy with developmental verbal dyspraxia, hinting that the EEG trait
    and the language phenotype share a developmental substrate. Whether ELP4
    regulatory variation sets a cortical-excitability and language-network
    vulnerability that only sometimes crosses the seizure threshold is an open,
    testable hypothesis.
  evidence:
  - reference: PMID:19172991
    reference_title: "Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with genome-wide linkage of CTS to 11p13 (HLOD 4.30)."
    explanation: >-
      Establishes the heritable EEG trait locus whose incomplete penetrance and
      language pleiotropy are the subject of this hypothesis.
  - reference: PMID:20825490
    reference_title: "Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves."
    explanation: >-
      Ties the same 11p13 locus to both the EEG trait and developmental verbal
      dyspraxia, the pleiotropy this hypothesis addresses.
  proposed_experiments:
  - experiment_id: exp_selects_elp4_penetrance
    name: ELP4 regulatory variation, excitability, and language
    description: >-
      In carriers stratified by ELP4 regulatory genotype, relate cortical
      excitability measures and language-network function to seizure occurrence,
      testing whether the same variation grades both excitability and language
      vulnerability.
    experiment_type:
      preferred_term: genotype-endophenotype stratification experiment
    readouts:
    - name: Excitability and language by genotype and seizure status
      target: pathophysiology#Genetic Predisposition to Cortical Hyperexcitability
      assays:
      - preferred_term: electroencephalography
      - preferred_term: language assessment
      direction: POSITIVE
    controls:
    - name: Non-carrier controls
      description: Individuals without the CTS-associated 11p13 genotype.
    decision_criterion: >-
      The hypothesis is supported if ELP4 regulatory genotype grades both
      cortical excitability and language-network measures, with seizures
      occurring above an excitability threshold.
    would_support:
    - pathophysiology#Genetic Predisposition to Cortical Hyperexcitability
📚

References & Deep Research

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Review response: resolve reversibility contradiction; merge main · 2026-09-14T14:48:25Z · View source

Response to the second ai4c-reviewer CHANGES_REQUESTED review on PR 8664, plus resolution of the merge conflict with main. Blocking finding: the entry asserted both that the neuropsychological deficits are reversible and, on one new causal edge, that 'the node is not asserted to be fully reversible'. The reviewer was right that the closing clause was factually wrong about its own file - three other places did assert reversibility. Softened all four locations to the wording the entry's own committed deep-research artifact uses ('largely reverse with remission. A minority carry residual, subtler cognitive/academic effects into later life'): - disease description: dropped 'transient', now 'largely improve with remission, though a minority have residual deficits' - Transient Language and Cognitive Dysfunction node description: dropped the bare 'reversible' and 'characteristically' - Language and Learning Difficulties phenotype description: dropped the leading 'Transient' - the edge description: deleted the '- so the node is not asserted to be fully reversible' clause The node name was deliberately left unchanged: it is the target of a bare-name pathograph edge, and renaming it would dangle that edge silently. The softening is now independently cited rather than just asserted. After merging main, this node carries main's own supports: REFUTE item on PMID:31645314 ('learning difficulties (14.5%) ... were common after CECTS diagnosis'), whose explanation already says it 'Cuts against the transient qualifier this node carries'. Merge conflict: four hunks in this file, all additive-vs-additive at a shared insertion point - main had added evidence blocks to two pre-existing edges and to two nodes, while this branch appended new sibling edges at the same places. Resolved by keeping both sides with main's block first. Verified after resolution: file parses, 16 top-level keys, 6 pathophysiology nodes, 8 phenotypes, 12 downstream edges all resolving to a real node or phenotype and all carrying evidence, 11 node-level evidence items, genes block intact. Also took the three non-blocking suggestions: removed curation-process meta-commentary from the GRIN2A gene descriptor (the sentence about KGX export stripping node prose); rewrote the PMID:15721962 explanation so it states what the paper found rather than what the edge 'no longer claims'; and hedged the PMID:34039076 febrile-seizure figure, since those authors describe their Colombian cohort as 'clearly different from other cohorts' with unusually prevalent febrile seizures, so 20% is not a general SeLECTS prevalence. Not done: the retired-enum prose in main's own PMID:28801973 explanation ('Graded PARTIAL rather than SUPPORT') that now sits in the merged region. It predates this PR and belongs to the tracked #10003 backlog.

Create: Self-Limited Epilepsy with Centrotemporal Spikes · 2026-07-18T13:30:51Z · View source

De-novo curation of self-limited epilepsy with centrotemporal spikes / SeLECTS / benign Rolandic epilepsy (MONDO:0007295), the most common focal epilepsy of childhood, a complex/polygenic self-limiting syndrome. No GeneReviews chapter for classic SeLECTS (the GRIN2A-Related Disorders chapter covers the Mendelian severe end); handled the NEC risk by anchoring on MONDO:0007295 vs the GRIN2A/ELP4 monogenic entities. claude_code deep research. Granular unbundled pathophysiology of the maturational mechanism: genetic predisposition (CTS/ELP4 trait) -> age-dependent perirolandic cortical hyperexcitability -> sleep-activated centrotemporal epileptiform discharges -> focal sensorimotor Rolandic seizures; plus transient language/cognitive dysfunction and age-dependent remission nodes. Two conforms_to links to the epilepsy module. Evidence snippet-verified: 19172991 (Strug, CTS->11p13/ELP4 linkage), 29056244 (GRIN2A at severe EAS end, absent from BECTS), 20825490 (11p13 dyspraxia pleiotropy). Prevalence (ANNUAL_INCIDENCE band) included. Discussions: epilepsy-aphasia-spectrum progression, maturational-remission mechanism, and CTS-trait penetrance/language-pleiotropy hypothesis. All snippets confirmed as exact substrings; validation and folded-hyphen pass.

Claude Code ▸
1. Disease Information
claude-haiku-4-5-20251001, claude-opus-4-8 15 citations 2026-07-18T09:22:25.756859

1. Disease Information

Overview. Self-Limited Epilepsy with Centrotemporal Spikes (SeLECTS) is the most common focal epilepsy syndrome of childhood — an age-dependent, genetically-influenced epilepsy that begins in a neurologically and cognitively normal school-age child, produces characteristic brief focal seizures arising from the lower (rolandic/perisylvian) sensorimotor cortex, shows a signature EEG pattern of high-amplitude centrotemporal spikes activated by drowsiness and sleep, and then reliably remits by mid-adolescence. It is the mild, self-limiting anchor of a broader continuum — the epilepsy-aphasia spectrum (EAS) — that at its severe end includes atypical benign focal epilepsy, epileptic encephalopathy with spike-and-wave activation in sleep (EE-SWAS / formerly CSWS/ESES), and Landau-Kleffner syndrome.

Key identifiers (verified against the local MONDO ontology, MONDO:0007295):

Resource ID
MONDO MONDO:0007295
OMIM 117100 (listed as "CENTRALOPATHIC EPILEPSY" / centrotemporal epilepsy)
Orphanet ORPHA:1945
DOID DOID:3329
ICD-9 345.80
ICD-11 (foundation) 1046279423
NCIT C116538
UMLS C0376532
MedGen 138210
GARD 0010287
MeSH "Epilepsy, Rolandic" (D019305)
SNOMED CT 44145005

Related MONDO entities worth distinguishing (NEC risk — see below): MONDO:0100020 atypical childhood epilepsy with centrotemporal spikes, MONDO:1060142 GRIN2A-related self-limited epilepsy with centrotemporal spikes, MONDO:0015587 rolandic epilepsy-speech dyspraxia syndrome, and MONDO:0010388 X-linked rolandic epilepsy, intellectual disability, and speech dyspraxia.

Synonyms / historical names: Benign Epilepsy with CentroTemporal Spikes (BECTS), Benign Childhood Epilepsy with CentroTemporal Spikes (BCECTS), Benign Rolandic Epilepsy (BRE), Benign Rolandic Epilepsy of Childhood (BREC), Rolandic epilepsy, centrotemporal epilepsy, centralopathic epilepsy, temporal-central focal epilepsy. The term "benign" is now deprecated by the ILAE 2022 nosology because it undersells the neurocognitive comorbidities in a subset of children (Specchio et al., Epilepsia 2022;63:1398–1442, doi:10.1111/epi.17241).

Data derivation: Disease-level aggregated resource. The knowledge here comes from clinical case series, natural-history cohorts, EEG phenotyping studies, and family-based linkage/genetics — not from individual EHR-derived patient records.

⚠️ NEC caution for the curator: "Rolandic epilepsy" is a genuine named-entity-confusion minefield. MONDO carries at least four distinct rolandic-epilepsy entities, and OMIM 117100 is intertwined with the ELP4/GRIN2A monogenic syndromes. The intended entry is the common, complex-inheritance, self-limited syndrome (MONDO:0007295) — not the rare Mendelian rolandic-epilepsy-plus-dyspraxia syndromes. Anchor DR content on MONDO:0007295 / OMIM:117100 and treat the GRIN2A monogenic disorder (MONDO:1060142) as a separate, severe-end entity.

2. Etiology

Causal factors — complex/multifactorial genetics, not Mendelian. SeLECTS is best understood as a complex genetic trait with strong developmental/age dependence, not a single-gene disorder. The classic view held that the EEG trait (centrotemporal sharp waves, CTS) was inherited as an autosomal dominant trait with age-dependent, incomplete penetrance, while the clinical epilepsy was a separate, multifactorial layer on top of it — most CTS carriers never seize. This "trait vs. syndrome" dissociation is the central etiologic idea (Bali et al.; Vears et al.).

Genetic risk factors: - ELP4 (11p13) — the centrotemporal sharp-wave EEG trait. Genome-wide linkage of the CTS EEG endophenotype mapped to 11p13, with fine-mapping implicating Elongator Protein Complex 4 (ELP4); the strongest signal was intron-9 variant rs986527 (Strug et al., Eur J Hum Genet 2009;17:1171–1181, PMID:19172991). "genome-wide linkage of CTS to 11p13 (HLOD 4.30)… the strongest evidence was with rs986527 in intron 9 of ELP4." The same 11p13 locus shows pleiotropy with developmental verbal dyspraxia (Pal et al., PMID:20825490), tying the EEG trait to the speech/language phenotype. - GRIN2A (16p13.2) — the epilepsy-aphasia spectrum, severe end. De novo and inherited pathogenic variants in GRIN2A (encoding the GluN2A subunit of the NMDA glutamate receptor) cause EAS disorders (Lesca et al., Nat Genet 2013;45:1061–1066, doi:10.1038/ng.2726/2727; Lemke et al., Nat Genet 2013;45:1067; Carvill et al., Nat Genet 2013;45:1073 — trio of 2013 papers, PMIDs ~23933818/23933819/23933820, verify before use). Crucially, GRIN2A variants concentrate at the atypical/severe end (atypical BECTS, EE-SWAS, LKS) and were not found in classic, uncomplicated SeLECTS probands: "pathogenic variants in GRIN2A were not detected in probands with benign childhood epilepsy with centrotemporal spikes (n = 81)" (review, PMID:29056244). So GRIN2A is a risk gene for the spectrum, not a cause of typical SeLECTS. - Other candidate/associated genes (weaker, mostly rare-variant or spectrum-associated): GRIN2B, RBFOX1/RBFOX3 (splicing regulators), DEPDC5, KCNQ2/KCNQ3, BDNF pathway. None is an established cause of common SeLECTS.

Environmental / demographic risk factors: - Age — the dominant "risk factor"; the window of vulnerability is early-mid childhood (see §8). - Male sex — modest male predominance (see §9). - Family history — of epilepsy, febrile seizures, or the CTS EEG trait; ~5–15% have a personal history of febrile seizures. - Genetic loading, not classical toxins/infections. No established environmental, infectious, or occupational trigger.

Protective factors: None established. Uniquely, the disease is intrinsically self-limiting — remission is programmed by brain maturation rather than by any modifiable protective exposure. No protective allele is characterized.

Gene–environment interactions: Not well characterized beyond the age/maturation dependence. The prevailing model is that a heritable cortical-excitability trait (CTS) is expressed clinically only within a developmental window, with maturation of the perisylvian/rolandic network driving both onset and spontaneous offset.

3. Phenotypes

The seizure semiology is stereotyped and is the diagnostic core. Suggested HPO terms in brackets.

Seizure phenotypes (clinical signs): - Focal aware seizures with unilateral facial (hemifacial) sensorimotor features — twitching/clonic movements of one side of the face, lips, tongue [Focal motor seizure / HP:0002384 Focal seizure; HP:0007359 Focal-onset seizure]. Frequency: near-defining; the majority of seizures. - Oropharyngeal / bulbar symptoms — guttural/gurgling sounds, a sensation in the throat, tonic/clonic contraction of oropharyngeal muscles. - Hypersalivation / drooling [HP:0002307 Drooling] — very frequent, a hallmark; the child cannot swallow saliva during the event. - Speech arrest / anarthria — inability to speak with preserved consciousness/comprehension [HP:0002499 Anarthria; HP:0001260 Dysarthria]. Very frequent. - Unilateral perioral/tongue paresthesia — numbness/tingling of cheek, lips, tongue, gums [HP:0003401 Paresthesia]. Frequent. - Preserved consciousness during typical events (the child is aware but cannot speak), a strongly characteristic feature. - Focal to bilateral tonic-clonic seizures — secondary generalization, especially from sleep [HP:0032794 Bilateral tonic-clonic seizure with focal onset; HP:0002069 Generalized tonic-clonic seizures]. Occurs in a substantial minority; often the presenting event that brings the child to attention. - Strong nocturnal / sleep-related predominance — ~70–80% of seizures occur during sleep, especially at sleep onset or shortly before waking [Nocturnal seizures]. Very frequent. - Todd's paresis (transient post-ictal hemiparesis/facial weakness) — occasional.

Seizure characteristics: - Age of onset: childhood, 3–14 yr, peak 7–9 yr (see §8). - Severity: typically mild; seizures are brief (usually 1–3 min). - Frequency: highly variable — many children have very few lifetime seizures (a single seizure in ~10–20%; overall low seizure burden). Course is episodic/infrequent. - Progression: self-limited; remits (see §8).

Neurocognitive / behavioral phenotypes (the "not-so-benign" tail): - Language impairment — expressive/receptive language, phonological processing, reading [HP:0002463 Language impairment; HP:0001328 Specific learning disability]. - Speech dyspraxia / apraxia — at the EAS end and in the ELP4-linked trait [HP:0011098 Speech apraxia]. - Attention deficit / ADHD-type problems [HP:0007018 Attention deficit hyperactivity disorder]. - Executive-function and working-memory deficits, and mild global cognitive underperformance [HP:0100543 Cognitive impairment]. - Fine/gross motor and visuomotor difficulties.

These deficits are typically mild, state-dependent, and largely reversible — MONDO's own definition captures it: "During the course of the active epilepsy, behavioral and neuropsychological deficits may be found, particularly in language and executive functioning. These deficits improve when seizures remit." They correlate with spike burden (spike-wave index) and worsen sharply if the child evolves toward EE-SWAS.

Quality-of-life impact: In typical SeLECTS, long-term QoL is good and near-normal after remission. During the active phase, the burden falls on school performance, language/reading, and attention rather than on physical disability; nocturnal seizures and parental anxiety also affect family QoL. Children who evolve to EE-SWAS/atypical forms can have significant, sometimes lasting, cognitive-linguistic impairment. Standardized QoL instrument data specific to SeLECTS are limited; most literature uses neuropsychological batteries rather than EQ-5D/SF-36.

4. Genetic / Molecular Information

Causal genes / architecture: SeLECTS is not monogenic. The best-supported molecular contributors: - ELP4 (HGNC:1171; 11p13) — associated with the centrotemporal sharp-wave EEG endophenotype (Strug 2009, PMID:19172991). ELP4 is a subunit of the Elongator complex, which modifies wobble-position uridines in tRNAs (translational/post-transcriptional regulation) and has roles in neuronal migration and paladin/cytoskeletal function. The associated variants are largely non-coding / intronic (e.g., rs986527), consistent with a regulatory rather than protein-coding effect. - GRIN2A (HGNC:4585; 16p13.2, encodes NMDA receptor subunit GluN2A) — causal at the severe/atypical end of the EAS (LKS, EE-SWAS, atypical BECTS), not in typical SeLECTS (Lesca/Lemke/Carvill Nat Genet 2013; review PMID:29056244).

Pathogenic variants (GRIN2A, EAS end): - Genes/HGNC: GRIN2A (HGNC:4585). - Variant classes: missense (often altering channel gating/agonist potency), nonsense/frameshift (loss of function/haploinsufficiency), splice-site, and structural/microdeletions spanning GRIN2A. - ACMG classification: pathogenic / likely pathogenic for the EAS phenotypes; many remain VUS. Curated in ClinVar and reviewed in GeneReviews (GRIN2A-Related Disorders, NCBI Bookshelf NBK385627). - Functional consequence — bidirectional: "GRIN2A pathogenic variants cause gain or loss of function of NMDA receptor… Gain of function can be targeted with uncompetitive NMDAR antagonists, while loss of function variants can be treated using NMDAR co-agonist serine" (PMID:29056244). Some epilepsy-associated variants reduce NMDAR trafficking and agonist potency (Sci Rep 2017, doi:10.1038/s41598-017-00115-w). - Origin: both germline inherited and de novo. - Allele frequency: pathogenic GRIN2A variants are rare in gnomAD; the CTS-associated ELP4 variants are common polymorphisms (consistent with a common-variant susceptibility trait).

Modifier genes: Poorly defined. The clinical expression (whether a CTS carrier develops seizures, and whether they stay mild or evolve to EE-SWAS) is thought to be modified by additional loci and developmental factors; RBFOX1/3, GRIN2B and others have been proposed as modifiers of severity/spectrum position.

Epigenetic information: No robust disease-specific methylation/chromatin signature is established. The ELP4/Elongator mechanism is itself a form of post-transcriptional (translational) regulation via tRNA modification, which is epigenetic-adjacent but not classic DNA methylation.

Chromosomal abnormalities: No recurrent aneuploidy. 16p13.2 microdeletions encompassing GRIN2A occur at the EAS end; these are detectable by chromosomal microarray.

Suggested gene descriptors: ELP4 (hgnc:1171), GRIN2A (hgnc:4585), GRIN2B (hgnc:4586), RBFOX1 (hgnc:21205).

5. Environmental Information

  • Environmental factors: None established as causal. No toxin, radiation, or pollutant is implicated.
  • Lifestyle factors: Sleep is the key state modulator — seizures and epileptiform discharges are dramatically activated by drowsiness and NREM sleep. Sleep deprivation can precipitate seizures/discharges (also exploited diagnostically). No dietary or activity risk factor is established.
  • Infectious agents: None. SeLECTS is not infectious/post-infectious; there is no pathogen trigger.

6. Mechanism / Pathophysiology

Core concept. SeLECTS is a disorder of the maturing perisylvian/rolandic cortical network — a transient, developmentally-timed hyperexcitability of the lower sensorimotor (rolandic) and adjacent perisylvian language cortex. The network's maturation both opens the window (onset in childhood) and closes it (spontaneous remission at puberty). It's the textbook example of an excitation–inhibition imbalance epilepsy that is genetically primed but developmentally gated.

Causal chain (upstream → downstream): 1. Genetic susceptibility — heritable cortical hyperexcitability trait (CTS EEG endophenotype linked to ELP4/11p13; at the severe end, NMDAR dysfunction from GRIN2A). [upstream trigger] 2. Perisylvian/rolandic cortical excitability imbalance — altered glutamatergic (NMDA-mediated) signaling and/or GABAergic interneuron regulation in a specific cortical territory, expressed within a developmental window [GO:0035249 excitatory chemical synaptic transmission, glutamatergic; GO:0007268 chemical synaptic transmission]. 3. Sleep-state amplification — NREM sleep and thalamocortical synchronization potentiate the epileptiform discharges (why seizures are nocturnal and the EEG "lights up" in sleep) → high-amplitude centrotemporal spikes with a characteristic horizontal dipole (negative centrotemporal / positive frontal). 4. Focal seizure generation — hypersynchronous discharge in the lower rolandic sensorimotor strip → hemifacial motor, oropharyngeal, salivatory, and speech-arrest semiology; occasional spread → focal-to-bilateral tonic-clonic. [clinical manifestation] 5. Spike-burden spillover to cognition — heavy interictal discharge (high spike-wave index), especially if it becomes near-continuous in sleep, disrupts sleep-dependent memory consolidation and language networks → the reversible language/attention/executive deficits; at the extreme, evolution to EE-SWAS/CSWS with more durable impairment. [downstream consequence] 6. Developmental resolution — network maturation normalizes excitability → seizures and CTS remit, deficits improve. [self-limitation]

Molecular pathways: Glutamatergic NMDA-receptor signaling (GRIN2A/GluN2A) is the best-defined molecular node; Elongator-complex tRNA wobble-uridine modification (GO:0002098) is the ELP4 mechanism, plausibly affecting translation of neurodevelopmental proteins and neuronal migration during corticogenesis (GO:0007420 brain development; GO:0001764 neuron migration).

Cellular processes / cell types: Cortical glutamatergic pyramidal neurons [CL:0000598 pyramidal neuron; CL:0000679 glutamatergic neuron] and GABAergic interneurons [CL:0000617 GABAergic neuron] of the rolandic/perisylvian cortex; E/I imbalance rather than cell death. This is a functional/excitability disorder — there is no neurodegeneration, gliosis, or structural lesion (imaging is normal by definition).

Protein dysfunction: GluN2A (GRIN2A) — altered NMDA receptor channel gating, reduced receptor trafficking, and altered agonist potency (both GoF and LoF variants) [UniProt Q12879].

Metabolic / immune involvement: No primary metabolic defect; no autoimmune mechanism in typical SeLECTS (contrast with the small subset of atypical/EE-SWAS cases where immune-mediated hypotheses are explored). No systemic biochemical abnormality.

Tissue-damage mechanisms: None — the "damage" is functional/electrophysiological (disrupted network function during the active period), fully reversible in typical cases.

Molecular profiling / advanced tech: Limited. No established transcriptomic, proteomic, metabolomic, or single-cell signature; genetics rests on family-based linkage (ELP4) and cohort sequencing (GRIN2A). FDG-PET case reports show focal rolandic metabolic changes but are not diagnostic (PMC10010858).

7. Anatomical Structures Affected

  • Organ / system level: Central nervous system — specifically the cerebral cortex [UBERON:0000956]. No other organ system is primarily involved.
  • Regional localization (the defining anatomy): The lower rolandic (peri-Rolandic) sensorimotor cortex around the central sulcus [UBERON:0002930], i.e., the lower precentral gyrus [UBERON:0002810] and postcentral gyrus [UBERON:0002811], within the broader perisylvian / opercular region adjacent to the lateral (Sylvian) sulcus [UBERON:0002721]. The "centrotemporal" EEG label reflects the C3/C4–T3/T4 electrode territory over this cortex.
  • Tissue / cell level: Cortical gray matter neurons — glutamatergic pyramidal neurons and GABAergic interneurons (CL terms in §6). Nervous tissue only.
  • Subcellular level: Postsynaptic density / glutamatergic synapse (NMDA receptors) [GO:0014069 postsynaptic density; GO:0045211 postsynaptic membrane]; cytoplasmic Elongator complex [GO:0033588 Elongator holoenzyme complex] for the ELP4 mechanism.
  • Lateralization: Individual seizures and their EEG discharges are unilateral/focal, but the trait is frequently bilateral or shifting on EEG (independent bilateral centrotemporal spikes are common). Clinically, the hemifacial semiology is unilateral, contralateral to the discharging hemisphere.

8. Temporal Development

  • Onset: Childhood, ages 3–14 years, with a peak at 7–9 years (~90% between 5 and 10). Onset pattern is essentially abrupt at the level of the first seizure but the underlying trait is present subclinically before that. Congenital/neonatal and adult onset do not occur (adult onset excludes the diagnosis).
  • Progression / course: Episodic and infrequent. Most children have few seizures over the active period; some have only a single lifetime seizure. Seizure burden is generally low; the "active" epilepsy phase lasts a few years.
  • Duration / remission: Self-limited — this is the defining temporal feature. Seizures remit spontaneously, usually by age 13, occasionally up to 16–18, essentially always by adulthood. Per MONDO: "onset of seizures between 3 and 14 years (peak 8-9 years) that usually resolve by age 13 years, but can occasionally occur up to age 18 years." Remission is spontaneous (maturational), not treatment-dependent — antiseizure medication controls seizures but does not change the age of remission.
  • Critical periods: The active-epilepsy childhood window is also the window of neurocognitive vulnerability (and the window in which heavy spike burden can, in a minority, evolve toward EE-SWAS). This makes the active period the target for monitoring language/attention and for intervention if atypical evolution appears. Recent work builds quantitative-EEG prediction models to flag children at risk of evolving to EE-SWAS (PMC11915340).

9. Inheritance and Population

Epidemiology: - Share of childhood epilepsy: the most common focal/idiopathic epilepsy of childhood; accounts for roughly 6–7% of all childhood epilepsy overall, rising to ~15–25% of epilepsies diagnosed between ages 5–15 (and ~15% of children aged 1–15 with non-febrile seizures). - Incidence: approximately 7–21 per 100,000 per year in children <15 years (reported range for seizures with centrotemporal spikes ~10.7–21/100,000; a UK birth-cohort study reported a lower crude annual incidence of ~5.3/100,000 across all ages, reflecting methodological differences). Orphanet epidemiology class: it is a rare-listed but relatively common childhood condition. (Birth-cohort/incidence data: PMC7285789.) - Prevalence: best expressed as incidence in the pediatric window given the self-limiting course; point prevalence in the general population is low because it clears by adulthood.

Genetic epidemiology: - Inheritance pattern: Complex / multifactorial. The EEG trait (CTS) shows autosomal-dominant-like segregation with age-dependent, incomplete penetrance; the clinical syndrome is multifactorial/polygenic. It is not a classic Mendelian disorder (the monogenic GRIN2A/ELP4 forms are separate, rarer entities). [Suggested inheritance term: HP:0010982 Polygenic inheritance / complex; the CTS trait historically HP:0000006 Autosomal dominant with incomplete penetrance.] - Penetrance: incomplete and age-dependent — most CTS-trait carriers never develop clinical seizures. - Expressivity: highly variable (single seizure → typical course → atypical/EAS evolution). - Anticipation / mosaicism / founder effects: not features of this disorder. - Consanguinity: not a recognized risk factor (complex, not recessive). - Carrier frequency: the CTS EEG trait is detectable in a notable fraction of first-degree relatives and in a small percentage of the general pediatric population who never seize.

Demographics: - Sex ratio: modest male predominance (~1.5:1; boy:girl roughly 6:4). - Geographic / ethnic distribution: worldwide, no strong geographic or ethnic clustering established. - Age distribution: confined to childhood (see §8).

10. Diagnostics

Diagnosis is clinical + EEG — a characteristic history plus the signature EEG in a normal child, with normal imaging.

  • EEG (the diagnostic centerpiece): normal background with high-amplitude, biphasic (di/triphasic) centrotemporal spikes/sharp waves, often with a horizontal dipole (surface-negative centrotemporal, surface-positive frontal), markedly activated by drowsiness and NREM sleep, frequently bilateral/independent or shifting. A sleep EEG greatly increases yield. ILAE 2022 criteria for typical SeLECTS require spike-wave index (SWI) <50% during NREM sleep with normal cognition/development; SWI ≥50% flags evolution toward EE-SWAS. [MAXO/LOINC: electroencephalography]
  • Neuroimaging (MRI): normal by definition — MRI is done largely to exclude a structural lesion when features are atypical; a lesion argues against the diagnosis. FDG-PET is not routine (case-level focal findings only).
  • Laboratory tests / biomarkers: none diagnostic; there is no blood, CSF, or metabolic biomarker. Labs serve only to exclude mimics.
  • Genetic testing: not required for typical SeLECTS (yield is low; it's a complex trait). Genetic testing (targeted GRIN2A sequencing, epilepsy gene panels, or chromosomal microarray for 16p13.2) is reserved for atypical presentations — early/regressive language loss, EE-SWAS/CSWS, atypical semiology, developmental concerns — i.e., the EAS end. GeneReviews GRIN2A-Related Disorders (NBK385627) covers testing.
  • Clinical diagnostic criteria: ILAE 2022 syndrome definitions (Specchio et al., doi:10.1111/epi.17241; epilepsydiagnosis.org SeLECTS overview) — mandatory features (normal development, typical semiology, characteristic sleep-activated centrotemporal EEG, onset 3–14 yr) and exclusionary features (structural lesion, developmental encephalopathy, SWI ≥50% with regression).
  • Differential diagnosis:
  • Self-limited epilepsy with autonomic seizures (Panayiotopoulos syndrome) — autonomic/vomiting semiology, younger, occipital-predominant.
  • Childhood occipital visual epilepsy (Gastaut type) — visual seizures.
  • Atypical BECTS / EE-SWAS (CSWS) / Landau-Kleffner — the severe EAS end; distinguished by high SWI, language regression, atypical/negative-myoclonic features.
  • Structural focal epilepsy (e.g., low-grade tumor, focal cortical dysplasia) — MRI abnormal.
  • Sleep parasomnias / benign sleep phenomena — no epileptiform EEG.
  • Screening: No population screening. Cascade/relative EEG screening is not indicated clinically (many trait carriers never seize).

11. Outcome / Prognosis

  • Survival / mortality: Excellent — essentially normal life expectancy. SeLECTS is not associated with increased mortality; SUDEP risk is negligible in typical cases. No disease-specific mortality.
  • Seizure outcome: Remission by mid-adolescence is the rule (see §8), independent of whether the child was treated. The great majority become seizure-free adults with normal neurological exams.
  • Neurocognitive outcome: Generally good. Language, attention, and executive deficits during the active phase are usually mild and largely reverse with remission. A minority carry residual, subtler cognitive/academic effects into later life, particularly those who had heavy spike burden or evolved toward atypical/EE-SWAS forms.
  • Morbidity / complications: the main "complications" are (a) neurocognitive/academic difficulty during the active years, and (b) rare atypical evolution to atypical BECTS, EE-SWAS/CSWS, or Landau-Kleffner — the outcomes that make "benign" a misnomer and that can leave lasting language impairment.
  • Prognostic factors: high spike-wave index / near-continuous sleep discharges, very early onset, atypical semiology (negative myoclonus, atonic/absence features), and language regression predict a more complicated course and possible EE-SWAS evolution; QEEG-based prediction models are emerging (PMC11915340).

12. Treatment

Overarching principle: many children need no antiseizure medication at all. Because seizures are typically infrequent, nocturnal, brief, and self-limiting, watchful waiting is a legitimate first choice — treatment is often reserved for frequent seizures, daytime or focal-to-bilateral tonic-clonic seizures, or significant family/child distress. [MAXO: watchful waiting / active surveillance; NCIT:C15986 Pharmacotherapy when drugs are used.]

Pharmacotherapy (when indicated) — generally monotherapy, low dose, short duration: - Levetiracetam [CHEBI:6437] — commonly used first-line; favorable tolerability. Evidence supports EEG normalization. - Sulthiame (sultiame) — an established, evidence-based option specifically studied in this syndrome. A 6-month randomized, double-blind, placebo-controlled monotherapy trial (Rating et al./Sulthiame Study Group, Epilepsia 2000, PMID:11051123) found "Twenty-five of the 31 STM-treated patients (81%) and 10 of the 35 placebo-treated patients (29%) completed the trial without any treatment failure" — a clear benefit. (Note a cautionary report of cognitive deterioration in some sulthiame-treated children, PMID:18184938 — dose/individual dependent.) - Carbamazepine [CHEBI:3387] / oxcarbazepine [CHEBI:7824] — historically standard and effective for the focal seizures, but with an important caveat: sodium-channel blockers can aggravate atypical forms and precipitate/worsen EE-SWAS/CSWS and negative myoclonus. Use cautiously; avoid if atypical features are present. - Valproate [CHEBI:39867] — broad-spectrum alternative, useful when generalization or atypical features are a concern. - Others: clobazam [CHEBI:31413], gabapentin, lacosamide, lamotrigine as alternatives; a comparative effectiveness study assessed antiseizure medications by spike-wave-index response (ScienceDirect S0887899423004551; NCBI Bookshelf NBK581163).

Atypical / EE-SWAS end (severe spectrum, escalated therapy): high-dose benzodiazepines (e.g., nocturnal clobazam/diazepam), corticosteroids / ACTH, and for confirmed GRIN2A cases, mechanism-targeted precision approaches — NMDAR antagonists (e.g., memantine [CHEBI:64312]) for gain-of-function variants and the NMDAR co-agonist L-serine for loss-of-function variants (rationale per PMID:29056244; still investigational). Sodium-channel blockers should generally be avoided in this group.

Non-pharmacological: neuropsychological/educational support, speech-language therapy for language/dyspraxia difficulties, and family counseling/reassurance about the benign natural history. [MAXO: speech therapy; educational intervention.]

Advanced/experimental therapeutics: gene- or receptor-targeted GRIN2A therapy remains research-stage; no gene therapy is approved for this syndrome. Surgery has no role in typical SeLECTS.

Treatment outcomes / adverse events: seizure control on monotherapy is generally good; the key safety issues are (1) drug-specific cognitive/behavioral side effects (levetiracetam irritability; topiramate/sulthiame cognitive effects) and (2) paradoxical aggravation by carbamazepine/oxcarbazepine in atypical cases. Because remission is age-programmed, medication can usually be withdrawn after a seizure-free interval without recurrence.

13. Prevention

  • Primary prevention: none — the disorder is genetically/developmentally determined and not preventable. No vaccine, no modifiable exposure.
  • Secondary prevention (early detection / intervention): the meaningful "prevention" target is atypical evolution — early recognition of rising spike-wave index, language regression, or atypical semiology so that aggressive treatment (and avoidance of aggravating sodium-channel blockers) can protect cognition. Serial sleep EEG and neuropsychological monitoring in at-risk children is the practical strategy.
  • Tertiary prevention: neurocognitive/educational and speech-language support to limit academic and language impact during the active phase; careful drug selection to avoid iatrogenic aggravation.
  • Genetic counseling: appropriate for families, but framed around complex inheritance / low recurrence risk for typical SeLECTS (with the caveat that the CTS EEG trait is more heritable than the clinical epilepsy). Targeted counseling applies for confirmed monogenic GRIN2A families (see GeneReviews NBK385627).
  • Immunization / public health / prophylaxis: not applicable.

14. Other Species / Natural Disease

  • Taxonomy: Human-specific syndrome [NCBITaxon:9606 Homo sapiens]. There is no recognized naturally-occurring animal analog of SeLECTS — the syndrome is defined by a human developmental cortical trait and a human EEG signature.
  • Breed / veterinary (OMIA): No established veterinary counterpart. (Idiopathic/genetic epilepsies exist in dogs, but no direct SeLECTS homolog is described.)
  • Orthologous genes: ELP4 and GRIN2A are deeply conserved across vertebrates — orthologs exist in mouse (Elp4, Grin2a), rat, and zebrafish — enabling mechanistic (not syndrome-recapitulating) modeling. [Use Alliance of Genome Resources / MGI for ortholog IDs.]
  • Comparative biology / transmission: not applicable; non-infectious, non-zoonotic, no cross-species susceptibility.

15. Model Organisms

  • Overall caveat (flag as a HUMAN_MODEL_MISMATCH candidate for the KB): there is no faithful animal model of the SeLECTS syndrome — no model reproduces the age-dependent centrotemporal EEG trait plus spontaneous pubertal remission. Models capture the molecular contributors, not the clinical entity.
  • Mouse (Mus musculus):
  • Grin2a knockout / point-mutant mice — model NMDA-receptor GluN2A dysfunction; show altered synaptic plasticity, cognition, and seizure susceptibility. Useful for the EAS/GRIN2A end, not typical SeLECTS. [MGI]
  • Elp4 / Elongator-complex mouse models — probe tRNA-modification and neurodevelopmental roles; relevant to the CTS EEG trait mechanism.
  • Applications: NMDAR pharmacology (memantine/serine rationale), synaptic E/I studies, neurodevelopmental corticogenesis.
  • Zebrafish / in vitro / iPSC: grin2a zebrafish and patient-derived iPSC neurons with GRIN2A variants are used for electrophysiological/functional characterization and variant classification (GoF vs LoF), which directly informs the precision-therapy split. [ZFIN; Cellosaurus]
  • Limitations: no model shows the disorder's signature — self-limitation — so questions about why the human perisylvian network remits at puberty remain a genuine knowledge gap best captured in the entry as a KNOWLEDGE_GAP/HUMAN_MODEL_MISMATCH discussion.

Citation summary (verify each before committing to YAML)

Claim Reference Status
ILAE 2022 nosology; "benign" deprecated; SeLECTS definition Specchio et al., Epilepsia 2022;63:1398–1442, doi:10.1111/epi.17241 ✅ verified via search
CTS EEG trait maps to ELP4 (11p13), rs986527 Strug et al., Eur J Hum Genet 2009;17:1171–81, PMID:19172991 ✅ verified
11p13 pleiotropy with verbal dyspraxia Pal et al., PMID:20825490 ✅ verified
GRIN2A at EAS end; not in typical SeLECTS; GoF/LoF precision therapy Review, PMID:29056244 ✅ verified
GRIN2A causes EAS (foundational trio) Lesca/Lemke/Carvill, Nat Genet 2013 (PMIDs ~23933818/819/820) ⚠️ from memory — verify
Sulthiame monotherapy RCT (81% vs 29%) Rating/Sulthiame Study Group, Epilepsia 2000, PMID:11051123 ✅ verified
Sulthiame cognitive-deterioration caution PMID:18184938 ✅ verified via search listing
Incidence/epidemiology (birth cohort) UK birth-cohort study, PMC7285789 ✅ verified via search
GRIN2A-Related Disorders (testing, counseling) GeneReviews NBK385627 ✅ verified via search
MONDO/OMIM/Orphanet identifiers local sqlite:obo:mondo MONDO:0007295 ✅ verified locally

Sources: - ILAE 2022 childhood syndromes position paper (Specchio et al.) - epilepsydiagnosis.org — SeLECTS overview - Strug et al. — ELP4 / centrotemporal sharp waves (PMID 19172991) - Pal et al. — 11p13 pleiotropy, verbal dyspraxia (PMID 20825490) - GRIN2A mutations in epilepsy-aphasia spectrum — review (PMID 29056244) - GRIN2A mutations cause epilepsy-aphasia spectrum disorders — Nature Genetics - GRIN2A-Related Disorders — GeneReviews (NBK385627) - Sulthiame monotherapy RCT (PMID 11051123) - Cognitive deterioration with sulthiame (PMID 18184938) - Temporal trends in Rolandic epilepsy incidence — birth cohort (PMC7285789) - OMIM 117100 - MedLink Neurology — SeLECTS - Effectiveness of antiseizure medications for SeLECTS (NBK581163) - QEEG prediction of evolution to EE-SWAS (PMC11915340) - Rolandic epilepsy — IntechOpen chapter

Bottom line, Harry: SeLECTS is the friendly-mostly-but-watch-it face of an excitation/inhibition imbalance in the maturing rolandic cortex — genetically primed (ELP4 for the EEG trait, GRIN2A for the severe end), developmentally gated to switch on around 7–9 and switch off by puberty, and for most kids it needs little more than reassurance and maybe low-dose levetiracetam or sulthiame. The one thing the entry should really lean on is the spectrum framing: the same machinery, cranked harder, becomes EE-SWAS/Landau-Kleffner, and that tail is where the cognition gets hurt. Two natural KB hooks jump out — a conforms_to link to the epilepsy_excitation_inhibition_imbalance module, and a HUMAN_MODEL_MISMATCH discussion around the unmodeled mystery of why it remits. Want me to go ahead and draft the actual kb/disorders/ YAML on this curate/selects-rolandic branch, running the terms and references through validation as I go?